Affimed Logo
  • Science and Technology
    • ICE® (innate cell engager) Molecules
    • ROCK® Platform
    • Publications and Posters
  • Pipeline and Clinical Trials
  • About Us
    • Management Board
    • Supervisory Board
    • Scientific Advisory Board
    • Partners
  • News and Events
  • Innately Affimed
  • Investors
    • Webcasts and Corporate Presentation
    • Analyst Coverage
    • Share Information
    • SEC and Financial Reports
    • Corporate Governance Affimed
    • Press Release Distribution
  • Careers
    • Culture
  • Contact
Menu

News and Events

See what’s new at Affimed

News

All categories
Earnings
Press Release
All years
2022
2021
2020
2019
2018
2017
2016
2015
2014
Affimed to Present at Deutsche Bank's 43rd Annual Health Care Conference

May 3, 2018

Affimed Introduces ROCK™ Platform for Tailored Immune Cell Engagers

May 3, 2018

Affimed Presents Poster at AACR Highlighting Progress Toward Novel EGFR-targeting Therapy

April 16, 2018

Affimed Reports Financial Results for Fourth Quarter and Year End 2017

March 20, 2018

Affimed Appoints Dr. Leila Alland as Chief Medical Officer

March 19, 2018

Affimed to Present Data on AFM24 at AACR Annual Meeting 2018

March 15, 2018

Affimed Announces Fourth Quarter and Year End 2017 Financial Results and Corporate Update Conference Call

March 13, 2018

Affimed to Present at the Cowen and Company 38th Annual Health Care Conference

March 8, 2018

Affimed Announces Closing of Public Offering of Common Stock and Exercise of Underwriters’ Option to Purchase Additional Shares

February 15, 2018

Affimed Announces Pricing of Public Offering of Common Stock

February 13, 2018

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25

Events

All
Scientific
Investors

There are no events planned at the moment.

WebcastsMore events

Affimed GmbH
Technologiepark
Im Neuenheimer Feld 582
69120 Heidelberg, Germany

Phone: +49 (0)6221-6743-60
Fax: +49 (0)6221 6743-649
email hidden; JavaScript is required

  • Affimed Science and Technology
    • ICE® (innate cell engager) Molecules
    • ROCK® Platform
    • Publications and Posters
  • About Us
    • Management Board
    • Supervisory Board
    • Scientific Advisory Board
    • Partners
  • News and Events
  • Investors
    • Webcasts and Corporate Presentation
    • Analyst Coverage
    • Share Information
    • SEC and Financial Reports
    • Press Release Distribution
    • Corporate Governance
  • Careers
    • Culture

© 2022 Affimed GmbH

  • Data Protection
  • Imprint
  • Contact